GlaxoSmithKline PLC (GSK)

43.67
0.35 0.81
NYSE : Health Care
Prev Close 43.32
Open 43.73
Day Low/High 43.30 / 43.78
52 Wk Low/High 37.24 / 45.58
Volume 1.96M
Avg Volume 2.82M
Exchange NYSE
Shares Outstanding 2.44B
Market Cap 104.66B
EPS 5.20
P/E Ratio 24.69
Div & Yield 2.00 (4.60%)

Latest News

5 Stocks to Sell Now Before It's Too Late

5 Stocks to Sell Now Before It's Too Late

These stocks could be toxic to your portfolio in the month ahead.

European Markets Mixed Ahead of Fed, BOJ Rate Calls on Wednesday

European Markets Mixed Ahead of Fed, BOJ Rate Calls on Wednesday

Oil bounces back, German producer price data point to a continued low inflation outlook.

GlaxoSmithKline (GSK) Stock Lower, Names Walmsley CEO

GlaxoSmithKline (GSK) Stock Lower, Names Walmsley CEO

GlaxoSmithKline (GSK) named Emma Walmsley, the company's head of consumer healthcare, as CEO beginning next March.

5 Things You Must Know Before the Market Opens Tuesday

5 Things You Must Know Before the Market Opens Tuesday

Wells Fargo CEO John Stumpf will apologize Tuesday to the bank's customers in Senate testimony; U.S. stock futures are rising; GlaxoSmithKline names a new CEO.

European Markets Mixed; Pharmaceuticals Group GSK Slips on News of Insider CEO

European Markets Mixed; Pharmaceuticals Group GSK Slips on News of Insider CEO

Oil prices fall, taking shares in the sector down with them, while German producer price data point to a continued low inflation outlook.

Bullish on SoftBank, ASML, Royal Dutch Shell and GlaxoSmithKline

Bullish on SoftBank, ASML, Royal Dutch Shell and GlaxoSmithKline

SoftBank is one of 4 stocks to fire up your portfolio, says ASTON/Pictet portfolio manager Benjamin Beneche.

Analysts Hit Reset Button On GlaxoSmithKline

Analysts Hit Reset Button On GlaxoSmithKline

A strong performance from the ViiV Healthcare venture and a foreign-exchange booster make the case for the U.K.'s leading pharmaceuticals business.

Did Mylan Purposefully Delay Generic Competition's Entry Into The Market?

Did Mylan Purposefully Delay Generic Competition's Entry Into The Market?

The Consumer Union is alleging that Mylan may have paid Teva to withhold its EpiPen competitor from the market.

GSK Presents Positive Results From Phase III FULFIL Study Of Closed Triple Combination Therapy FF/UMEC/VI Versus Symbicort® Turbohaler® In COPD At ERS International Congress

GSK Presents Positive Results From Phase III FULFIL Study Of Closed Triple Combination Therapy FF/UMEC/VI Versus Symbicort® Turbohaler® In COPD At ERS International Congress

GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced the presentation of further data from the pivotal phase III FULFIL study with investigational closed triple combination therapy fluticasone...

Positive Results From The COPD Salford Lung Study Published In The NEJM And Presented At European Respiratory Congress

Positive Results From The COPD Salford Lung Study Published In The NEJM And Presented At European Respiratory Congress

GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ:INVA) today announced that the results from the pioneering Salford Lung Study (SLS) have been published in the New England Journal of Medicine (NEJM).

Gilead Sinking Stock Price Calls Out for New Rescue Plan

Gilead Sinking Stock Price Calls Out for New Rescue Plan

Investors once OK with waiting patiently for a Gilead rebound are growing frustrated, even angry, at the company's lack of progress.

How Will GlaxoSmithKline (GSK) Stock React to New HIV Drug Development?

How Will GlaxoSmithKline (GSK) Stock React to New HIV Drug Development?

GlaxoSmithKline (GSK) is working on a two-pill HIV regimen that could potentially change the standard of HIV treatment and push it ahead of rival pharmaceutical companies.

Henderson Revises Global Dividend Expectations Lower For 2016

Henderson Revises Global Dividend Expectations Lower For 2016

London based investment manager warns of further falls in U.K dividends.

9 Stocks for the Bank of England's Corporate-Bond Purchases

9 Stocks for the Bank of England's Corporate-Bond Purchases

Which stocks will be most favored by the corporate-bond purchases?

GSK Unveils Campaign To Help Prevent Meningitis

GSK Unveils Campaign To Help Prevent Meningitis

Parents, young adults urged to educate themselves about meningitis B, responsible for one-third of U.S. cases[1]

4 Stocks to Buy in This Vulnerable Market

4 Stocks to Buy in This Vulnerable Market

This market is like a leaky helium balloon; watch out for sudden downdrafts.

We've Just Found the 'Apple' of Biotechnology

We've Just Found the 'Apple' of Biotechnology

Two companies, one a tech giant and the other a Big Pharma stalwart, have formed a joint venture that's bringing disruptive technology to new drug development.

Here's Why GlaxoSmithKline's Stock Is Ready to Scale New Heights

Here's Why GlaxoSmithKline's Stock Is Ready to Scale New Heights

This big pharma blue chip is on a growth trajectory that often eludes companies of its massive size.

Alphabet and Glaxo Team Up to Jumpstart Your Profits

Alphabet and Glaxo Team Up to Jumpstart Your Profits

The Google parent and Big Pharma major have announced a joint venture into the developing world of bioelectronics treatments.

Portfolio Roundup: Humira Helps Buoy AbbVie Shares

Portfolio Roundup: Humira Helps Buoy AbbVie Shares

The drug maker continued to rally Monday.

GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'

GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'

GlaxoSmithKline's (GSK) Dr. Slaoui believes the company's partnership with Alphabet (GOOGL) will create new nano devices to treat chronic diseases.

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet

GlaxoSmithKline Inks Medical 'Bioelectronics' Partnership With Alphabet

The pharmaceutical giant is teaming up with Google's parent with as much as $715 million in joint investments.

Morning Movers: GSK, GOOGL, SCTY, TSLA

Morning Movers: GSK, GOOGL, SCTY, TSLA

GlaxoSmithKline and Google's parent Alphabet announced their joint plan to pioneer a new form of electronic medical treatment.

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

Uber reaches an agreement for its China operations to be acquired by local rival Didi Chuxing; Fed's Dudley says don't rule out rate hike this year; U.S. stock futures rise.

Glaxo Teams Up with Alphabet on Bioelectronic Med Deal

Glaxo Teams Up with Alphabet on Bioelectronic Med Deal

The companies will invest $715 million over seven years to develop miniature implantable devices to help chronic diseases.

AstraZeneca Earnings, Sales Edge Above Forecasts

AstraZeneca Earnings, Sales Edge Above Forecasts

CEO Soriot says the company's pipeline is progressing well, and predicts a boost to full-year earnings from a decline in the pound.

3 Stocks Boosting The Health Care Sector Higher

3 Stocks Boosting The Health Care Sector Higher

TheStreet highlights 3 stocks pushing the health care sector higher today.